Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 1
1982 1
1983 4
1984 8
1985 6
1986 7
1987 8
1988 18
1989 32
1990 38
1991 26
1992 45
1993 52
1994 57
1995 54
1996 70
1997 61
1998 63
1999 63
2000 66
2001 63
2002 67
2003 87
2004 97
2005 105
2006 126
2007 128
2008 172
2009 161
2010 191
2011 227
2012 261
2013 305
2014 283
2015 292
2016 286
2017 276
2018 281
2019 244
2020 252
2021 193
2022 92
Text availability
Article attribute
Article type
Publication date

Search Results

4,203 results
Results by year
Filters applied: . Clear all
Page 1
Supplementation With Vitamin D and Omega-3 Fatty Acids and Incidence of Heart Failure Hospitalization: VITAL-Heart Failure.
Djoussé L, Cook NR, Kim E, Bodar V, Walter J, Bubes V, Luttmann-Gibson H, Mora S, Joseph J, Lee IM, Albert CM, Buring JE, Gaziano JM, Manson JE; VITAL Research Group. Djoussé L, et al. Circulation. 2020 Mar 3;141(9):784-786. doi: 10.1161/CIRCULATIONAHA.119.044645. Epub 2019 Nov 11. Circulation. 2020. PMID: 31709816 Free PMC article. Clinical Trial. No abstract available.
Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study.
Kobyliak N, Abenavoli L, Falalyeyeva T, Mykhalchyshyn G, Boccuto L, Kononenko L, Kyriienko D, Komisarenko I, Dynnyk O. Kobyliak N, et al. Minerva Med. 2018 Dec;109(6):418-428. doi: 10.23736/S0026-4806.18.05845-7. Epub 2018 Sep 13. Minerva Med. 2018. PMID: 30221912 Clinical Trial.
METHODS: A total of 48 patients met the criteria for inclusion. They were randomly assigned to receive "Symbiter Omega" combination of probiotic biomass supplemented with flax and wheat germ oil (250 mg of each, concentration of omega-3 fatty acids …
METHODS: A total of 48 patients met the criteria for inclusion. They were randomly assigned to receive "Symbiter Omega" combination o …
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial.
Kalstad AA, Myhre PL, Laake K, Tveit SH, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Fagerland MW, Solheim S, Seljeflot I, Arnesen H; OMEMI Investigators. Kalstad AA, et al. Circulation. 2021 Feb 9;143(6):528-539. doi: 10.1161/CIRCULATIONAHA.120.052209. Epub 2020 Nov 15. Circulation. 2021. PMID: 33191772 Clinical Trial.
Elderly patients are at particularly increased cardiovascular risk after myocardial infarction, but few trials address this group specifically. Omega-3 fatty acids hold the potential to reduce cardiovascular events with limited adverse effects in this …
Elderly patients are at particularly increased cardiovascular risk after myocardial infarction, but few trials address this group specifical …
A Low ω-6 to ω-3 PUFA Ratio (n-6:n-3 PUFA) Diet to Treat Fatty Liver Disease in Obese Youth.
Van Name MA, Savoye M, Chick JM, Galuppo BT, Feldstein AE, Pierpont B, Johnson C, Shabanova V, Ekong U, Valentino PL, Kim G, Caprio S, Santoro N. Van Name MA, et al. J Nutr. 2020 Sep 1;150(9):2314-2321. doi: 10.1093/jn/nxaa183. J Nutr. 2020. PMID: 32652034 Free PMC article. Clinical Trial.
BACKGROUND: Recent literature suggests that the Western diet's imbalance between high omega-6 (n-6) and low omega-3 (n-3) PUFA intake contributes to fatty liver disease in obese youth. OBJECTIVES: We tested whether 12 wk of a low n-6:n-3 …
BACKGROUND: Recent literature suggests that the Western diet's imbalance between high omega-6 (n-6) and low omega-3 (n- …
Bioavailability of marine n-3 fatty acid formulations.
Dyerberg J, Madsen P, Møller JM, Aardestrup I, Schmidt EB. Dyerberg J, et al. Prostaglandins Leukot Essent Fatty Acids. 2010 Sep;83(3):137-41. doi: 10.1016/j.plefa.2010.06.007. Prostaglandins Leukot Essent Fatty Acids. 2010. PMID: 20638827 Clinical Trial.
The use of marine n-3 polyunsaturated fatty acids (n-3 PUFA) as supplements has prompted the development of concentrated formulations to overcome compliance problems. The present study compares three concentrated preparations - ethyl esters, free fa …
The use of marine n-3 polyunsaturated fatty acids (n-3 PUFA) as supplements has prompted the development of conc …
Oral Bioavailability of Omega-3 Fatty Acids and Carotenoids from the Microalgae Phaeodactylum tricornutum in Healthy Young Adults.
Stiefvatter L, Lehnert K, Frick K, Montoya-Arroyo A, Frank J, Vetter W, Schmid-Staiger U, Bischoff SC. Stiefvatter L, et al. Mar Drugs. 2021 Dec 10;19(12):700. doi: 10.3390/md19120700. Mar Drugs. 2021. PMID: 34940699 Free PMC article. Clinical Trial.
The microalgae Phaeodactylum tricornutum (PT) contains valuable nutrients such as proteins, polyunsaturated omega-3 fatty acids (n-3 PUFA), particularly eicosapentaenoic acid (EPA) and some docosahexaenoic acid (DHA), carotenoids such as fucoxan …
The microalgae Phaeodactylum tricornutum (PT) contains valuable nutrients such as proteins, polyunsaturated omega-3 fatty …
A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.
Cornu C, Mercier C, Ginhoux T, Masson S, Mouchet J, Nony P, Kassai B, Laudy V, Berquin P, Franc N, Le Heuzey MF, Desombre H, Revol O. Cornu C, et al. Eur Child Adolesc Psychiatry. 2018 Mar;27(3):377-384. doi: 10.1007/s00787-017-1058-z. Epub 2017 Oct 5. Eur Child Adolesc Psychiatry. 2018. PMID: 28993963 Clinical Trial.
We performed a randomised placebo-controlled trial to evaluate the efficacy of omega-3 fatty acids. METHODS: Children aged 6-15 years with established diagnosis of ADHD were randomised 1:1 to receive either supplements containing docosahexaenoic acid ( …
We performed a randomised placebo-controlled trial to evaluate the efficacy of omega-3 fatty acids. METHODS: Chi …
Plasma estradiol levels and antidepressant effects of omega-3 fatty acids in pregnant women.
Nishi D, Su KP, Usuda K, Chang JP, Hamazaki K, Ishima T, Sano Y, Ito H, Isaka K, Tachibana Y, Tanigaki S, Suzuki T, Hashimoto K, Matsuoka YJ. Nishi D, et al. Brain Behav Immun. 2020 Mar;85:29-34. doi: 10.1016/j.bbi.2019.02.014. Epub 2019 Feb 15. Brain Behav Immun. 2020. PMID: 30776476 Clinical Trial.
BACKGROUND: Omega-3 polyunsaturated fatty acids (PUFAs) reduce depressive symptoms through an anti-inflammatory effect, and injection of both omega-3 PUFAs and estradiol (E2) induces antidepressant-like effects in rats by regulating the e …
BACKGROUND: Omega-3 polyunsaturated fatty acids (PUFAs) reduce depressive symptoms through an anti-inflammatory …
Could Omega 3 fatty acids reduce the risk of contrast-induced nephropathy in patients undergoing coronary angiography? A randomized controlled trial.
Alrowaie FA, Almatham KI, Alsamadi F, Bashir MS, Munshi HH. Alrowaie FA, et al. Saudi J Kidney Dis Transpl. 2021 Mar-Apr;32(2):328-335. doi: 10.4103/1319-2442.335443. Saudi J Kidney Dis Transpl. 2021. PMID: 35017325 Free article. Clinical Trial.
Contrast medium-induced nephropathy (CIN) is a leading cause of acquired acute kidney injury and has been associated with prolonged hospitalization and adverse clinical outcomes. This study aimed to determine if omega 3 fatty acids reduce the risk of C …
Contrast medium-induced nephropathy (CIN) is a leading cause of acquired acute kidney injury and has been associated with prolonged hospital …
4,203 results